RAD Virtual Meeting - Sponsored by Pfizer - August 25, 2021

JOIN OUR VIRTUAL MEETING

A Closer Look at Atopic Dermatitis and the Role of the JAK/STAT Pathway

Date: Wednesday, August 25, 2021
Time: 8:00 - 9:30 PM (EST)

About the Meeting

Pfizer Inc., invites you to an engaging discussion during which experts within the dermatology community, Jonathan I. Silverberg, MD, PhD, MPH, and Zakiya P. Rice, MD, will provide an overview of atopic dermatitis (AD) and the burden of this disease, as well as discuss the pathophysiology of AD and cytokine signaling through the JAK/STAT pathway. This presentation will not discuss any therapeutics, and Pfizer does not have any JAK inhibitors approved for the treatment of AD.

Speakers

Jonathan I. Silverberg, MD, PhD, MPH
Associate Professor
Director of Clinical Research
Director of Patch Testing
George Washington University School of Medicine
and Health Sciences
Washington, District of Columbia

Zakiya P. Rice, MD
Associate, Dermatology Associates of Georgia
Adjunct Clinical Professor
Department of Dermatology
Emory University School of Medicine
Atlanta, Georgia

Agenda

8:00 PM	Welcome and Introduction
8:05 PM	What's Happening with RAD!
8:10 PM	A Closer Look at Atopic Dermatitis and the Role of the JAK/STAT Pathway
9:15 PM	Q&A and Closing Remarks
9:30 PM	Meeting Ends

This program is offered by Pfizer and does not include any continuing education credits. The content of the program and opinions expressed by speakers are those of the company and/or speakers and not of RAD. Speakers present on behalf of the supporting company and together are responsible for providing information in compliance with the US Food and Drug Administration regulations.

PP-A2D-USA-0609

July 2021